SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-023714
Filing Date
2020-04-07
Accepted
2020-04-07 12:15:07
Documents
1
Period of Report
2020-04-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 18315
  Complete submission text file 0001209191-20-023714.txt   19677
Mailing Address 1490 O'BRIEN DRIVE, SUITE A MENLO PARK CA 94025
Business Address 1490 O'BRIEN DRIVE, SUITE A MENLO PARK CA 94025 (650) 352-4150
Forty Seven, Inc. (Issuer) CIK: 0001667633 (see all company filings)

IRS No.: 474065674 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O FORTY SEVEN, INC. 1490 O'BRIEN DRIVE, SUITE A MENLO PARK CA 94025
Business Address
Takimoto Chris H (Reporting) CIK: 0001743780 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38554 | Film No.: 20778963